Lycopene

Lycopene has been studied in 70 papers since 2009: 36 observational studies in people, 14 in animals, 2 in cells, 17 reviews; 21 in the past year. The newest story, Nov 2, 2026: “Nanoparticles with two agents reduced cartilage damage in mice”.

Intervention

70 papers study it39 more mention it51 findingsUpdated

PubChemChEBIMeSH

More supplements

3 new papers in 30 daysSee all 108 papers on lycopene

At a glance

Lycopene improves cognition and reduces oxidative stress in mice, with independent labs reporting both results again. Human studies link higher serum lycopene with lower mortality, while a study links lycopene with higher Alzheimer's risk in people with neurogenesis-centered susceptibility to brain aging. Some authors work at companies, and some papers declare company ties.

51 findings in 25 papers from 2017 to 2026, 4 of them since August 2026

Independent labs found the same change in cells, mice and people. 21 independent labs in 7 countries; 23 trials, none about aging, 13 with no results posted.

“There was no statistically significant association between dietary consumption of lycopene and bladder cancer risk (Adjusted model: HRQ5 vs. Q1 = 1.04, 95% CI 0.82-1.33; P for trend = 0.590).”
Association of dietary tomato intake with bladder cancer risk in a prospective cohort of 101,683 individuals with 12.5 years of follow-upAging2021doi:10.18632/aging.203252

None of its findings points the other way.

Cells, mice and humans: replicated by independent labs. Worms or flies: a single group.
  • 21 independent labs in 7 countries
  • 23 trials, none about aging, 13 with no results posted
  • Funders: National Natural Science Foundation of China and others
  • 4 of 48 findings with company ties
  • 1 of 23 trials sponsored by its developers
  • Humans36
  • Animals12
  • Model organisms2
  • Cells2

What did studies of lycopene find?

33

Studies of lycopene measured 33 outcomes; the most studied are oxidative stress and ROS signaling (4 studies), cognitive function (3) and cellular senescence (2).

Oxidative stress and ROS signaling

downin cells2downin mice2

4 studies
  1. Lycopene decreases oxidative stress and ROS signaling in TMAO-treated EPCs.

    “TMAO increased SA-β-gal-positive cell number and ROS production, while reducing the expression of AMPK and SIRT1. These effects were attenuated by Lyc.”

    Cellsin TMAO-treated EPCsendothelial progenitor cells

    Lycopene attenuates trimethylamine-N-oxide-induced senescence in endothelial progenitor cells via the AMPK/SIRT1 pathway

    Clinical and experimental hypertension (New York, N.Y. : 1993)

  2. Lycopene inhibits oxidative stress and ROS signaling in cells.

    “lycopene significantly increased the activities of antioxidant enzymes, and the ability to inhibit oxygen radicals, and decreased the content of malondialdehyde.”

    Cellstestis

    Supplementing ageing male laying breeders with lycopene alleviates oxidative stress in testis and improves testosterone secretion

    Theriogenology

  3. Lycopene decreases oxidative stress and ROS signaling in mice.

    “Moreover, these alterations are associated with a decrease in oxidative stress in the senile osteoporosis model.”

    Animals8 weeks

    Lycopene Improves Bone Quality in SAMP6 Mice by Inhibiting Oxidative Stress, Cellular Senescence, and the SASP

    Molecular nutrition & food research

  4. Lycopene decreases oxidative stress and ROS signaling in mice (age-associated oxidative stress).

    “LYC supplementation decreased age-associated oxidative stress via suppression of malondialdehyde levels”

    Animalsage-associated oxidative stress

    Lycopene Supplementation Attenuates Oxidative Stress, Neuroinflammation, and Cognitive Impairment in Aged CD-1 Mice

    Journal of agricultural and food chemistry

More on Oxidative stress and ROS signaling

Cognitive function

upin mice2upin humans1

3 studies
  1. Lycopene improves cognitive function in aging mice.

    “after treatment with LYC for 3 months, brain aging and age-related cognitive deficits were effectively managed”

    Animalsin aging mice3 months

    Lycopene alleviates age-related cognitive deficit via activating liver-brain fibroblast growth factor-21 signalling

    Redox biology

  2. Lycopene improves cognitive function in humans.

    “found a protective effect for HDL cholesterol, lycopene, carotenoids, ω-3 and ω-6 fatty acids, and vitamins B, C, D, and E”

    Review

    Contribution of Biological Age-Predictive Biomarkers to Nutrition Research: A Systematic Review of the Current Evidence and Implications for Future Research and Clinical Practice

    Advances in nutrition (Bethesda, Md.)

  3. Lycopene improves cognitive function in mice (age-associated cognitive impairment).

    “Behavioral tests revealed that chronic LYC supplementation alleviated age-associated memory loss and cognitive defects.”

    Animalsage-associated cognitive impairmentchronic

    Lycopene Supplementation Attenuates Oxidative Stress, Neuroinflammation, and Cognitive Impairment in Aged CD-1 Mice

    Journal of agricultural and food chemistry

Cellular senescence

downin cells1downin mice1

2 studies
  1. Lycopene decreases cellular senescence in TMAO-treated EPCs.

    “TMAO increased SA-β-gal-positive cell number and ROS production, while reducing the expression of AMPK and SIRT1. These effects were attenuated by Lyc.”

    Cellsin TMAO-treated EPCsendothelial progenitor cells

    Lycopene attenuates trimethylamine-N-oxide-induced senescence in endothelial progenitor cells via the AMPK/SIRT1 pathway

    Clinical and experimental hypertension (New York, N.Y. : 1993)

  2. Lycopene decreases cellular senescence in mice.

    “In addition, there is a reduction in osteoblast and osteocyte senescence and the SASP in the bone tissues of the SAMP6 mice.”

    Animalsbone8 weeks

    Lycopene Improves Bone Quality in SAMP6 Mice by Inhibiting Oxidative Stress, Cellular Senescence, and the SASP

    Molecular nutrition & food research

More on Cellular senescence

Apoptosis

downin cells1downin chicken cells1

2 studies
  1. Lycopene inhibits apoptosis in cells.

    “Apoptosis was inhibited by regulating the expression of apoptosis-inducing and anti-apoptosis factors.”

    Cellstestis

    Supplementing ageing male laying breeders with lycopene alleviates oxidative stress in testis and improves testosterone secretion

    Theriogenology

  2. Lycopene inhibits apoptosis in chicken cells (D-gal-induced and naturally aged ovarian cultures).

    “Moreover, lycopene promoted cell proliferation and inhibited apoptosis in both D-gal-induced and naturally aged ovaries.”

    CellsD-gal-induced and naturally aged ovarian culturesovaryfemales

    Lycopene ameliorates oxidative stress in the aging chicken ovary via activation of Nrf2/HO-1 pathway

    Aging

More on Apoptosis

Insulin resistance

downin rats2

2 studies
  1. Lycopene decreases insulin resistance in rats during skin aging, in aged rats.

    “all data demonstrated that Ly might reverse insulin resistance via SIRT1 during skin aging”

    Animalsduring skin aging, in aged ratsskin

    Lycopene ameliorates skin aging by regulating the insulin resistance pathway and activating SIRT1

    Food & function

  2. Lycopene decreases insulin resistance in rats.

    “Ly could reactivate SIRT1 and improve insulin resistance”

    Animals

    Lycopene ameliorates insulin resistance and increases muscle capillary density in aging via activation of SIRT1

    The Journal of nutritional biochemistry

More on Insulin resistance

Vascular endothelial function

upin humans1

1 study
  1. Lycopene improves vascular endothelial function in humans.

    “continuous intake of lycopene-containing products may have beneficial effects on vascular endothelial function in healthy adults”

    Reviewlycopene-containing productscontinuous

    Effect of Intake of Lycopene-Containing Products on Vascular Endothelial Function in Healthy Adults: A Systematic Review with Meta-Analysis

    Nutrients

Reactive hyperemia peripheral arterial tonometry index

upin humans1

1 study
  1. Lycopene increases reactive hyperemia peripheral arterial tonometry index in humans.

    “15 mg of lycopene intake for 8 weeks significantly increased the reactive hyperemia peripheral arterial tonometry index”

    Review15 mg8 weeks

    Effect of Intake of Lycopene-Containing Products on Vascular Endothelial Function in Healthy Adults: A Systematic Review with Meta-Analysis

    Nutrients

More on Reactive hyperemia peripheral arterial tonometry index

Flow-mediated dilation

upin humans1

1 study
  1. Lycopene increases flow-mediated dilation in humans (MD 1.36, 95% CI 0.20 to 2.51).

    “revealed a significant increase in FMD (MD = 1.36, 95% confidence interval: 0.20, 2.51, p = 0.02)”

    Reviewlycopene-containing product≥7 daysn = 182

    Effect of Intake of Lycopene-Containing Products on Vascular Endothelial Function in Healthy Adults: A Systematic Review with Meta-Analysis

    Nutrients

More on Flow-mediated dilation

Cellular

upin cells1

1 study
  1. Lycopene improves cellular in TMAO-treated EPCs.

    “TMAO-induced suppression of EPCs' functionality was alleviated by Lyc, but this effect was reversed by siAMPK and siSIRT1.”

    Cellsin TMAO-treated EPCsendothelial progenitor cells

    Lycopene attenuates trimethylamine-N-oxide-induced senescence in endothelial progenitor cells via the AMPK/SIRT1 pathway

    Clinical and experimental hypertension (New York, N.Y. : 1993)

Testosterone

upin animals1

1 study
  1. Lycopene increases testosterone.

    “With the increase in lycopene levels, the testosterone content in the plasma was significantly higher than in the control group.”

    Animalsdietaryplasma6 weeksmalesn = 96

    Supplementing ageing male laying breeders with lycopene alleviates oxidative stress in testis and improves testosterone secretion

    Theriogenology

More on Testosterone

All 33

What is lycopene linked with?

10

Studies link lycopene with 10 measures, among them cognitive function, benign prostatic hyperplasia and type 2 diabetes.

Cognitive function

upin humans1

1 study
  1. Lycopene is associated with cognitive function in humans (Hispanic/Latino adults) (β=0.19; p≤0.04).

    “total carotenoids (β=0.26), α-carotene (β=0.22), β-cryptoxanthin (β=1.0), lutein+zeaxanthin (β=0.21), and lycopene (β=0.19) were significantly (all ps ≤ 0.04) associated with cognitive performance.”

    HumansHispanic/Latino adults

    Associations Between Dietary Carotenoids and Cognitive Performance in Older Hispanic/Latino Adults are Stronger in Men and Smokers

    The Journal of nutrition

Benign prostatic hyperplasia

downin humans1

1 study
  1. Lycopene is associated with benign prostatic hyperplasia in humans after adjusting for phytochemicals.

    “the risk was significantly lower among participants with the highest intake of lycopene or soybean polyphenols than among those with the lowest intake.”

    Humansafter adjusting for phytochemicalsprostatehighest versus lowest intakelong-term follow-upmalesn = 120

    Intake of foods containing phytochemicals is correlated with benign prostatic hyperplasia development: a long-term follow-up study

    Scientific reports

More on Benign prostatic hyperplasia

Type 2 diabetes

downin humans1OR 0.092

1 study
  1. Lycopene is associated with type 2 diabetes in humans after full covariate adjustment and false discovery rate correction (OR 0.092, 95% CI 0.033-0.256).

    “lycopene was the only supplement that remained associated with lower diabetes prevalence after full covariate adjustment and false discovery rate correction (odds ratio 0.092; 95% confidence interval 0.033-0.256”

    Humansafter full covariate adjustment and false discovery rate correctionn = 2,381

    Dietary supplements, epigenetic aging, and diabetes status: A cross-sectional NHANES study

    Maturitas

More on Type 2 diabetes

Metabolically healthy obesity

upin humans1

1 study
  1. Lycopene predicts metabolically healthy obesity in the complete model.

    “SHAP and LIME analyses revealed that added vitamin B12, lycopene, caffeine, theobromine, and lutein/zeaxanthin were the strongest positive predictors in the complete model.”

    Humansin the complete modeln = 8,914

    Prediction of metabolically healthy obesity based on dietary nutrients: a comparative analysis of six machine learning models with SHAP and LIME interpretation

    Eating and weight disorders : EWD

Age-related macular degeneration

downin humans1OR 0.37

1 study
  1. Lycopene is linked with a lower risk of age-related macular degeneration in humans (OR: 0.37; 95% CI: 0.18-0.78).

    “those in highest quartile of lycopene (OR: 0.37; 95% CI: 0.18-0.78) was negatively associated with risk of AMD”

    Humanshighest quartile vs first quartileserumn = 1,478

    Association between serum carotenoid concentrations and risk of major age-related eye diseases among middle-aged and older adults

    Frontiers in medicine

More on Age-related macular degeneration

Cardiovascular mortality

downin humans1HR 0.77

1 study
  1. Lycopene is linked with a lower risk of cardiovascular mortality in humans (metabolic syndrome) (HR 0.77 (95% CI 0.61, 0.97), p = 0.039).

    “Analysis revealed an inverse dose-response relationship between serum lycopene levels and cardiovascular mortality risk.”

    Humansmetabolic syndromeserummedian of 16.8 yearsn = 6,601

    Impact of serum carotenoids on cardiovascular mortality risk in middle-aged and elderly adults with metabolic syndrome

    Frontiers in nutrition

Alzheimer's disease

upin humans1OR 1.07

1 study
  1. Lycopene is linked with a higher risk of Alzheimer's disease in individuals with a neurogenesis-centred biological susceptibility to brain ageing (OR 1.07, 95% CI 1.01–1.14).

    “Increased plasma lycopene concentrations (OR [95% CI] = 1.07 [1.01, 1.14]), higher red meat (OR [95% CI] = 1.10 [1.03, 1.19]), and lower poultry consumption (OR [95% CI] = 0.93 [0.87, 0.99]) were associated with an increased risk for AD in individuals with a neurogenesis-centred susceptibility.”

    Humansin individuals with a neurogenesis-centred biological susceptibility to brain ageing12 yearsn = 371

    Association of dietary and nutritional factors with cognitive decline, dementia, and depressive symptomatology in older individuals according to a neurogenesis-centred biological susceptibility to brain ageing

    Age and ageing

More on Alzheimer's disease

Aging disorders

downin reviews1

1 study
  1. Lycopene lowers the risk of aging disorders.

    “Lycopene-rich foods are found to prevent or attenuate aging disorders in various research.”

    Review

    Pharmacological potentials of lycopene against aging and aging-related disorders: A review

    Food science & nutrition

More on Aging disorders

Cardiovascular disease mortality

downin humans1HR 0.53

1 study
  1. Lycopene is linked with a lower risk of cardiovascular disease mortality in humans (Q4 compared to Q1) (HR 0.53, 95% CI 0.32-0.96).

    “0.53 (0.32,0.96), 0.48 (0.32,0.72) and 0.63 (0.41,0.97) for CVD mortality (Ptrend<0.05).”

    HumansQ4 compared to Q1total-lycopeneserummedian follow-up of 10.7 yearsn = 7,452

    Associations of different isomeric forms of serum lycopene with cardiovascular disease and all-cause mortality

    International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition

Mortality

downin humans1HR 0.49

1 study
  1. Lycopene is linked with a lower risk of mortality in humans (Q4 compared to Q1) (HR 0.49, 95% CI 0.38-0.63).

    “hazard ratio (with 95% confidence intervals) associated with Q4 compared to Q1 of serum total-lycopene, trans-lycopene and cis-lycopene was 0.49 (0.38,0.63)”

    HumansQ4 compared to Q1total-lycopeneserummedian follow-up of 10.7 yearsn = 7,452

    Associations of different isomeric forms of serum lycopene with cardiovascular disease and all-cause mortality

    International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition

Has lycopene been tested in people?

0 of 23 about aging

Yes: 36 observational studies in people have been published, and 23 trials are registered.

In trials

All 13

Trial sponsors

How this record changed

  1. Summary written from the findings.

Latest

Dec 2025: 2Jan 2026: 6Feb 2026: 2Mar 2026: 2Apr 2026: 1May 2026: 2Jun 2026: 0Jul 2026: 2Aug 2026: 5Sep 2026: 2Oct 2026: 2Nov 2026: 228 papers in 12 months
Bioactive Materials

Nanoparticles with two agents reduced cartilage damage in mice

In an animal experiment, cartilage-targeting particles reduced cartilage loss in 18-month-old male mice, with six per group, assessed after two months.In an animal experiment, cartilage-targeting particles reduced cartilage loss in 18-month-old male mice, with six per group, assessed after two months.

Mouse studyBones and joints

See all 108 papers on lycopene